Mode
Text Size
Log in / Sign up
N/A Completed N=91 Diagnostic

Reliability, Sensitivity and Validity of the 6 Minute Step Test in Chronic Obstructive Pulmonary Disease (COPD) Patients

Source: ClinicalTrials.gov NCT01298661 ↗
Enrolled (actual)
91
Serious AEs
Results posted
Sep 2013
Primary outcomePrimary: First "Six Minute Step Test" Performance — 166.4; 114.0; 76.6 steps

Summary

Chronic Obstructive Pulmonary Disease (COPD) leads to a reduction in exercise capacity that affects the quality of life and increases mortality of these patients. So, exercise tests are considered as an essential component of the clinical evaluation of the patients with COPD. The objective of this study is to evaluate the reproducibility sensitivity and validity of the Six Minute Step Test (6MST) in patients with COPD and in health volunteers, and verify its relation with the "Body-Mass Index, Airways Obstruction, Dyspnea and Exercise Capacity" Index (BODE). This Observational, Transversal, Prospective study will be conducted in the "Special Unit of Respiratory Physiotherapy", of the "Federal University of São Carlos". To participate in this study, 120 subjects, both gender, will be invited and will be allocated in five groups: Group I (30 healthy young subjects of 17 to 27 years old), Group II (30 healthy elderly individuals of 60 to 75 years old), and patients COPD, 60 to 80 years old, with mild, moderate, severe and very severe obstruction determined by the forced expiratory volume in one second (FEV1) by forced vital capacity (FVC) relation "FEV1/FVC" <70% and FEV1 in predict percentage < 80% composing the Group III (20 COPD patients in GOLD stage I), Group IV (20 COPD patients in GOLD stage II) and Group V (20 patients COPD stages III and IV). All subjects will be submitted to body composition and anthropometric assessment, pulmonary function test, three 6-minutes walk test (6MWT) and three 6MST. Furthermore, the patients of the groups III, IV and V will answer the Modified Medical Research Council (mMRC) scale, and BODE index will be calculated to each of them.

Outcome Measures

OutcomeResultp-value
PRIMARY
First "Six Minute Step Test" Performance
166.4; 114.0; 76.6
PRIMARY
Second "Six Minute Step Test" Performance
170.7; 114.5; 82.4
PRIMARY
Third "Six Minute Step Test" Performance
172.3; 111.3; 86.4
SECONDARY
First "Six Minute Walk Test" Distance
643.5; 504.5; 380.4
SECONDARY
Second "Six Minute Walk Test" Distance
648.2; 513.6; 391.0
SECONDARY
Third "Six Minute Walk Test" Distance
648.3; 502; 392.4
SECONDARY
"Body-Mass Index, Airflow Obstruction, Dyspnea, Exercise Capacity" Index (BODE Index)
3
SECONDARY
First "Six Minute Walk Test" Exertion Perception
1; 0.5; 1
SECONDARY
Second "Six Minute Walk Test" Exertion Perception
0.5; 0.5; 1
SECONDARY
Third "Six Minute Walk Test" Exertion Perception
1; 1; 2
SECONDARY
First "Six Minute Step Test" Exertion Perception
2; 2.5; 2
SECONDARY
Second "Six Minute Step Test" Exertion Perception
2; 1.5; 2.5
SECONDARY
Third "Six Minute Step Test" Exertion Perception
1; 2; 2.5
SECONDARY
First "Six Minute Walk Test" Peripheral Oxygen Saturation
96.7; 94.5; 90.4
SECONDARY
Second "Six Minute Walk Test" Peripheral Oxygen Saturation
96.4; 95.1; 90.3
SECONDARY
Third "Six Minute Walk Test" Peripheral Oxygen Saturation
96.1; 94.7; 89.7
SECONDARY
First "Six Minute Step Test" Peripheral Oxygen Saturation
95.8; 95; 90.1
SECONDARY
Second "Six Minute Step Test" Peripheral Oxygen Saturation
96; 94.9; 90.5
SECONDARY
Third "Six Minute Step Test" Peripheral Oxygen Saturation
95.8; 94.9; 90.3
SECONDARY
First "Six Minute Walk Test" Heart Rate
143; 115; 113
SECONDARY
Second "Six Minute Walk Test" Heart Rate
144; 115; 112
SECONDARY
Third "Six Minute Walk Test" Heart Rate
145; 112; 114
SECONDARY
First "Six Minute Step Test" Heart Rate
154; 116; 117
SECONDARY
Second "Six Minute Step Test" Heart Rate
159; 118; 117
SECONDARY
Third "Six Minute Step Test" Heart Rate
156; 117; 116

Eligibility Criteria

Inclusion Criteria

  • Young and elderly healthy subjects presented pulmonary function within the normal range, confirmed by spirometry
  • Patients with clinical and spirometric diagnosis of COPD

Exclusion Criteria

  • Lung disease exacerbated
  • Decompensated heart disease
  • Rheumatic, neurological or orthopedic disease, preventing them from doing the tests by limiting the exercise
  • Peripheral oxygen saturation < 80% without physical effort
  • Subjects who does not complete the first day of evaluation
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01298661). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search